Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis

被引:0
|
作者
Barrett, B. F. [1 ,5 ]
Wehmeyer, M. [2 ]
Kolb, J. [1 ]
Ostermann, T. [3 ]
Sappok, T. [4 ]
机构
[1] St Lukas Klin, Liebenau Kliniken, Liebenau, Germany
[2] Ludwig Maximilians Univ Munchen, Fac Psychol & Pedag, Dept Pedag & Rehabil, Munich, Germany
[3] Univ Witten Herdecke, Fac Hlth, Dept Psychol & Psychotherapy, Witten, Germany
[4] Bielefeld Univ, Univ Hosp OWL, Univ Clin People Neurodev Disorders, Mara, Bielefeld, Germany
[5] Liebenau Kliniken, St Lukas Klin, Siggenweilerstr 11, D-88074 Liebenau, Germany
关键词
antipsychotics; challenging behaviour; diagnostic assessment; psychiatric disorder; psychosis; scale of emotional development; CHALLENGING BEHAVIOR; PSYCHIATRIC-ASSESSMENT; MENTAL-ILLNESS; BASE-LINE; DIAGNOSIS; CHILDREN; INDIVIDUALS; PERSPECTIVE; AGGRESSION; PREVALENCE;
D O I
10.1111/jir.13136
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
BackgroundCompared with the general population, adults with an intellectual developmental disorder (IDD) are more likely to develop mental health problems and to receive high levels of psychotropic medication, particularly antipsychotics. The emotional development (ED) approach may help to better understand the nature of challenging behaviour (CB) and tailor treatment and support accordingly. The aim of this retrospective study was to investigate the impact of the ED approach on the prescription of psychotropic medication during inpatient psychiatric treatment.MethodsThe clinical data of 1758 patients were analysed within a retrospective study design over a period of 12 years. ED level was assessed (1) for the first time (INITIAL-SEO), (2) during a previous hospital stay (PAST-SEO) or (3) not at all (NO-SEO). The effects of the ED assessment and the respective intervention during the current admission on the number of psychotropics and the number and dosage of antipsychotics were analysed for the total sample, including those with CB, autism spectrum disorders and psychosis. Group differences were analysed by a chi-square test and a one-factorial analysis of variance. For analysing the impact of the application of the ED approach on psychotropic medication, a covariance model was applied. Changes between the subsamples were analysed by t-tests for dependent samples.ResultsThe ED approach had a significant impact on reducing the overall amount of psychotropic medication and the dosage of antipsychotics in all patients with IDD. These effects were mainly attributable to those showing CB. In patients with autism spectrum disorders, the developmental approach reduced the number of antipsychotics. No effects could be observed in patients with psychosis; in this subsample, both the number and dosage of antipsychotics increased.ConclusionsThe application of the ED approach in the current hospital stay reduced the number of psychotropic drugs and the number and dosage of antipsychotics, especially in those patients with IDD and CB, but also in those with autism spectrum disorders.
引用
收藏
页码:941 / 953
页数:13
相关论文
共 50 条
  • [11] Development of practice-guided measures to improve guideline adherence in psychotropic medication for adults with intellectual disabilities
    Schuetzwohl, Matthias
    Kroenke, Indra
    Reupert, Annegret
    Stasch, Nicole
    Mayer, Lea
    Krumm, Silvia
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES, 2023,
  • [12] Improving evaluation of psychotropic medication for adults with developmental disabilities living in community settings
    Blough, D
    Pulliam, B
    Page, TJ
    Sweeney, V
    Doughert, R
    Grim, M
    BEHAVIORAL INTERVENTIONS, 2006, 21 (02) : 73 - 83
  • [13] Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities
    Valdovinos, Maria G.
    Henninger-McMahon, Meara
    Schieber, Elizabeth
    Beard, Lisa
    Conley, Brenna
    Haas, Annette
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES, 2016, 62 (03) : 200 - 211
  • [14] Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities
    Wise, Elizabeth
    Holingue, Calliope
    Klein, Ann
    Caoili, Andrea
    Charlot, Lauren
    Barnhill, Jarrett
    Beasley, Joan B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (01): : 65 - 77
  • [15] THE IMPACT OF DEPRESSIVE EPISODES ON THE LEVEL OF EMOTIONAL DEVELOPMENT IN ADULTS WITH INTELLECTUAL DEVELOPMENTAL DISORDER
    Schmidt, M.
    Haferburg, T.
    Sappok, T.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2021, 65 (08) : 732 - 732
  • [16] International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities
    Deb, Shoumitro
    Kwok, Henry
    Bertelli, Marco
    Salvador-Carulla, Luis
    Bradley, Elspeth
    Torr, Jennifer
    Barnhill, Jarret
    WORLD PSYCHIATRY, 2009, 8 (03) : 181 - 186
  • [17] Transitional challenges: Psychotropic medication and residential setting among young adults with intellectual disabilities
    Houseworth, James
    Ticha, Renata
    Pettingell, Sandra L.
    Stancliffe, Roger J.
    Bershadsky, Julie
    JOURNAL OF POLICY AND PRACTICE IN INTELLECTUAL DISABILITIES, 2024, 21 (03)
  • [18] The use of psychotropic medication for the management of problem behaviours in adults with intellectual disabilities living in Canada
    Bradley, Elspeth
    Cheetham, Thomas
    ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES, 2010, 4 (03) : 12 - 26
  • [19] Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution
    Kelly, Susan
    Su, Yani
    INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2015, 53 (04) : 289 - 300
  • [20] The Impact of Sensory Diets on Adults With Intellectual and Developmental Disabilities (IDD)
    Gawlas, Catherine
    Blaskowitz, Meghan
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2020, 74 (04):